申请人:FORMA THERAPEUTICS INC
公开号:WO2020061255A1
公开(公告)日:2020-03-26
The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).